The need for long-term follow-up studies after treatment of superficial bladder cancer (Tis/Ta/T1), especially after intravesical chemotherapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology
D000970:Antineoplastic Agents